A 10-year survey on prevalence and occurrence rate of multi-drug resistant Mycobacterium tuberculosis in Latin American and Mediterranean Families: A Systematic review and meta-analysis

S. Rouhi, Daem Rooshani, P. Shakib, F. Ahangarkani, R. Ramazanzadeh, Cellular
{"title":"A 10-year survey on prevalence and occurrence rate of multi-drug resistant Mycobacterium tuberculosis in Latin American and Mediterranean Families: A Systematic review and meta-analysis","authors":"S. Rouhi, Daem Rooshani, P. Shakib, F. Ahangarkani, R. Ramazanzadeh, Cellular","doi":"10.29252/JBRMS.5.1.51","DOIUrl":null,"url":null,"abstract":"Introduction: Latin American and Mediterranean (LAM) is a family of Mycobacterium tuberculosis (M. tuberculosis). Drug resistant in M. tuberculosis LAM family is a major problem in the world population. Our objective of this study was to determine the prevalence of M. tuberculosis LAM family with multi-drug resistant (MDR) in the worldwide by a metaanalysis and systematic review. Materials and methods: Data sources of this study were 68 original articles (2001-2012) which were published in different databases. Research articles with full text in English were selected. Review articles, congress abstracts, studies that were reported in languages other than English and also studies that were not available for us in abstract or full text were excluded. Data that were obtained from prevalence and occurrence rate of MDR M. tuberculosis LAM family were analyzed using meta-analysis random effects models with software package Meta R, Version 2.13 (P < 0.10). Results: During 10 years, lowest rate of prevalence was observed in 2010 and 2006 (95% CI: 5.91%-6.95%) and highest prevalence rate was in 2006 (95% CI: 17.48%24.05%). prevalence of MDRM. tuberculosis analysis showed positive MDR between them (95% CI: 10.30%11.23%). Prevalence for negative MDR was 9.22% (95% CI: 8.3%10.2%). Conclusion: Our study showed that M. tuberculosis LAM family is prevalent in Europian countries. LAM sub lineage was a major focus of studies that carried out in different countries. The proper technique for prevention of transmission of M. tuberculosis is necessary.","PeriodicalId":15047,"journal":{"name":"Journal of Basic Research in Medical Sciences","volume":"5 1","pages":"51-61"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Basic Research in Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29252/JBRMS.5.1.51","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Introduction: Latin American and Mediterranean (LAM) is a family of Mycobacterium tuberculosis (M. tuberculosis). Drug resistant in M. tuberculosis LAM family is a major problem in the world population. Our objective of this study was to determine the prevalence of M. tuberculosis LAM family with multi-drug resistant (MDR) in the worldwide by a metaanalysis and systematic review. Materials and methods: Data sources of this study were 68 original articles (2001-2012) which were published in different databases. Research articles with full text in English were selected. Review articles, congress abstracts, studies that were reported in languages other than English and also studies that were not available for us in abstract or full text were excluded. Data that were obtained from prevalence and occurrence rate of MDR M. tuberculosis LAM family were analyzed using meta-analysis random effects models with software package Meta R, Version 2.13 (P < 0.10). Results: During 10 years, lowest rate of prevalence was observed in 2010 and 2006 (95% CI: 5.91%-6.95%) and highest prevalence rate was in 2006 (95% CI: 17.48%24.05%). prevalence of MDRM. tuberculosis analysis showed positive MDR between them (95% CI: 10.30%11.23%). Prevalence for negative MDR was 9.22% (95% CI: 8.3%10.2%). Conclusion: Our study showed that M. tuberculosis LAM family is prevalent in Europian countries. LAM sub lineage was a major focus of studies that carried out in different countries. The proper technique for prevention of transmission of M. tuberculosis is necessary.
拉丁美洲和地中海家庭耐多药结核分枝杆菌患病率和发病率的10年调查:系统回顾和荟萃分析
拉丁美洲和地中海(LAM)是结核分枝杆菌(M. tuberculosis)的一个家族。结核分枝杆菌LAM家族的耐药是世界人口中的一个主要问题。本研究的目的是通过荟萃分析和系统评价,确定结核分枝杆菌LAM家族多药耐药(MDR)在全球的流行情况。材料和方法:本研究的数据来源为发表在不同数据库中的68篇(2001-2012)原创文章。选择有英文全文的研究文章。综述文章、大会摘要、以英语以外的语言报道的研究以及不能以摘要或全文提供的研究均被排除在外。对MDR结核分枝杆菌LAM家族患病率和发生率数据采用Meta -分析随机效应模型,应用2.13版本Meta R软件包进行分析(P < 0.10)。结果:10年间,2010年和2006年患病率最低(95% CI: 5.91% ~ 6.95%), 2006年患病率最高(95% CI: 17.48% ~ 24.05%)。MDRM的患病率。结核分析显示耐多药耐药阳性(95% CI: 10.30% ~ 11.23%)。耐多药阴性的患病率为9.22% (95% CI: 8.3%10.2%)。结论:本研究显示结核分枝杆菌LAM家族在欧洲国家普遍存在。LAM亚谱系是在不同国家开展的研究的主要焦点。预防结核分枝杆菌传播的适当技术是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信